Board of Directors

Jennifer A. Baird joined the board of directors of SeaStar Medical in 2024 and in July 2025 our Board of Directors appointed Ms. Baird as Chair of the Board of Directors. Ms. Baird brings leadership, management, and executive experience to provide effective support and oversight of the Company’s operations. Since 2023, Ms. Baird has served as the Executive Chair of the Board of Directors for Culturewell, Co., an organization that delivers actionable insights for healthcare infection prevention through environmental sampling testing and germ risk assessments. From 2017 to 2022, Ms. Baird founded and served as the Chief Executive officer of Fifth Eye Inc., a software medical device company developing and commercializing healthcare related clinical algorithms and predictive analytics using steaming physiologic parameter inputs. From 2010 to 2017, Ms. Baird was the chief executive officer of Accio Energy, Inc., an organization that focused on developing transformational renewable energy technology. In addition, Ms. Baird has co-founded other healthcare-based companies including Accuri Cytometers, Inc. (acquired by Becton Dickinson) and Sonetics Ultrasound, Inc. Ms. Baird served in Chief Executive Officer-Director roles for each of Fifth Eye, Inc., Accio Energy, Inc., Accuri Cytometers Inc., and Sonetics Ultrasound, Inc. Ms. Baird has served as a director for Hope Clinic, a nonprofit, since 2009 and an advisor for Michigan Founders Fund, since 2020.

Ms. Baird has a Bachelor of Arts in Organizational Psychology/Leadership from the University of Michigan and a Master of Business Administration from Kellogg Graduate School of Management Northwestern University.

John Neuman retired from The Dow Chemical Company in 2023 following 30 years of service, most recently as Vice President of Global Financial Accounting. In this position, he directed a team of approximately 350 professionals with responsibilities for financial accounting and reporting for a global network of more than 400 legal entities, including SEC filings. His tenure at Dow included finance integration and reporting responsibilities for several transactions, including the Rohm & Haas and Dow Corning acquisitions, and the Dow/DuPont merger. Prior to joining Dow, Mr. Neuman was an audit manager for Deloitte & Touche LLP. He holds a degree in accounting from Michigan State University and previously served as a member of the Michigan State University External Advisory Board for the Department of Accounting and Information Systems. He is a Certified Public Accountant (inactive).

Since 2019, Eric Schlorff has served as the Chief Executive Officer of SeaStar Medical, responsible for the management, strategy, and operations of the company. He has extensive experience in financial planning and managing large, complex organizations and as well as deep knowledge of SeaStar Medical’s business operations, including the scientific basis, regulatory requirements and sales and marketing channels.

Prior to joining SeaStar Medical in 2016, Mr. Schlorff spent more than 20 years at Dow Chemical Company, serving in multiple roles including Global Director of Alternative Investments for the Dow Chemical Pension Plan, Global Finance Leader for Crop Protection & Seeds at Dow AgroSciences, Global Market Intelligence Leader at Dow AgroSciences, Global Financial Manager of Royalties at Dow Agrosciences, Senior Investment Manager of Alternative Investments at Dow Chemical Company, New Business Development of Pharmaceuticals at Dow Chemical Company, Global Financial Analyst within the New Businesses division at Dow Chemical Company, and Global Financial Analyst within Dow AgroSciences at Dow Chemical Company.

Mr. Schlorff has a bachelor’s degree in chemistry and biology from MacMurray College, an M.S. in pharmacology from Southern Illinois University School of Medicine and a master’s in business administration from University of Illinois Urbana-Champaign.

Kenneth Van Heel has served as a Director on the Board of Directors of SeaStar Medical since 2021 and previously served from 2011 to 2015. He brings experience in venture capital investment, financial analysis and reporting, risk management, strategic planning, and public company operations, as well as his expertise and skills in working with companies in the medical device and healthcare industries. Mr. Van Heel is the Chief Executive Officer at Motorcity Systems, a software provider in the trucking and transportation industry and also serves as a Director and Advisor at Gantec, Inc., a biotechnology company for agricultural products. Prior to joining Motorcity Systems, Mr. Van Heel spent 35 years at Dow Chemical Company in various roles in strategic planning, investments, private equity, venture capital and business development. 

Mr. Van Heel holds a bachelor’s degree in materials science and engineering from Illinois Institute of Technology and master’s degree in business administration from DePaul University.

Bernadette N. Vincent joined the board of directors of SeaStar Medical in 2024, bringing industry expertise and experience, and providing valuable insight and knowledge to the Company’s operation. Previously, she held various roles at Satellite Healthcare Inc., a national non-profit kidney care company offering treatment options education, applied pragmatic research and clinical trials, and chronic, home and acute dialysis therapies, including as President & Chief Operating Officer from 2021 to 2023, as Chief Operating Officer from 2020 to 2021, and as Chief Field Operations Officer from 2018 to 2020. Prior to that from 2015 to 2017, Ms. Vincent served in various divisions as Chief Operating Officer for Mednax, Inc., a national medical group providing multi-specialty physician and health system services company. Prior to that, Ms. Vincent served in various leadership roles with Fresenius Medical Care North America. She was Group Vice President from 2008-2014; Vice President of Operations from 2006-2008. Ms. Vincent’s Board of Directors experience spanned from 2014-2023, where she served from 2018 to 2023, as a director for Satellite Healthcare Inc., serving on the Quality, Safety & Patient Experience; Government & Compensation, 10 Executive & Strategy committees. Ms. Vincent served as a director for the National Kidney Foundation, California & Pacific Northwest chapter since 2021, and was Founder Board member for the Laureate Academy Charter School from 2014 to 2015, serving on the Finance Committee. 

Ms. Vincent holds a bachelor of science in Nursing from Dillard University and Master of Business Administration from Pepperdine University.